<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-6343</journal-id>
<journal-title><![CDATA[Farmacia Hospitalaria]]></journal-title>
<abbrev-journal-title><![CDATA[Farm Hosp.]]></abbrev-journal-title>
<issn>1130-6343</issn>
<publisher>
<publisher-name><![CDATA[Grupo Aula Médica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-63432019000600003</article-id>
<article-id pub-id-type="doi">10.7399/fh.11188</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Assessment of adherence to treatment with injectable extended-release antipsychotics within a pharmacotherapeutic follow-up program]]></article-title>
<article-title xml:lang="es"><![CDATA[Evaluación de la adherencia al tratamiento con antipsicóticos inyectables de liberación prolongada dentro de un programa de seguimiento farmacoterapéutico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gallastegui]]></surname>
<given-names><![CDATA[Carmen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández-Vega]]></surname>
<given-names><![CDATA[Hadriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Piñeiro]]></surname>
<given-names><![CDATA[Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rey-Gómez-Serranillos]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olivares]]></surname>
<given-names><![CDATA[José M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3b"/>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Heras-Liñero]]></surname>
<given-names><![CDATA[Elena de las]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3b"/>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Servicio Gallego de Salud Xerencia de Xestión Integrada de Vigo Servicio de Farmacia]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Servicio Gallego de Salud Xerencia de Xestión Integrada de Vigo Farmacia de Atención Primaria]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A3a">
<institution><![CDATA[,Instituto de Investigación Biomédica Galicia Sur Servicio de Psiquiatría y Área de Investigación en Neurociencia Traslacional ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A3b">
<institution><![CDATA[,Centro de Investigación Biomédica en Red de Salud Mental  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A3c">
<institution><![CDATA[,Servicio Gallego de Salud Xerencia de Xestión Integrada de Vigo ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>43</volume>
<numero>6</numero>
<fpage>177</fpage>
<lpage>181</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-63432019000600003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-63432019000600003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-63432019000600003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective To describe an injectable extended-release antipsychotic pharmacotherapeutic follow-up program and to assess adherence among patients included in the program.  Method A coordinated program is described involving hospital and primary care pharmacy, which included electronic prescription, reviewing, and dispensing of injectable antipsychotic agents in mental health and primary health care centers. Adherence to treatment was assessed in a 1-month prospective observational cross-sectional study which included all patients under treatment with injectable extended-release antipsychotics in a health area of more than 500,000 inhabitants. The variables collected were: medication administered, frequency of administration, administration center, and whether or not the patient attended the center. Patients were considered to have adhered to treatment if they had attended their appointments within a margin of ± 7 days.  Results A total of 919 patients and 1,073 appointments were included. Eleven mental health units and 40 primary health care centers participated in data collection. In 95.7 % (1,027) of cases, the patients attended the appointment. No differences were found in adherence between drugs or administration frequency. However, differences were found between mental health units and primary health care centers. Patient adherence was slightly higher in mental health units (97.6% vs 91.1%; P &lt; 0.001).  Conclusions The high adherence rate shows that the described follow-up program is effective. Further long-term studies are needed to confirm this trend.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo Describir un programa de seguimiento farmacoterapéutico de antipsicóticos inyectables de liberación prolongada y evaluar la adherencia de los pacientes incluidos.  Método Se describe un programa de prescripción electrónica, validación y dispensación de antipsicóticos a unidades de salud mental y centros de salud, coordinado entre farmacia de hospital y de atención primaria. La adherencia al tratamiento se evaluó mediante un estudio prospectivo, observacional y transversal de un mes realizado en un área sanitaria a más de 500.000 habitantes, en el que se incluyeron todos los pacientes en tratamiento con un antipsicótico inyectable de liberación prolongada. Las variables recogidas fueron: medicamento administrado, frecuencia de administración, centro de administración y si el paciente acudía o no a la administración, considerando que acudía si lo hacía en ± 7 días.  Resultados Se incluyeron un total de 919 pacientes y 1.073 consultas programadas. En la recogida de datos participaron 11 unidades de salud mental y 40 centros de salud. En un 95,7% (1.027) de los casos, los pacientes acudieron a la administración del antipsicótico inyectable de liberación prolongada. No se encontraron diferencias en la adherencia entre los medicamentos ni entre frecuencias de administración, pero sí con respecto al centro donde se administraba el medicamento (unidades de salud mental frente a centros de salud), presentando una ligera mayor adherencia los pacientes de las unidades de salud mental (97,6% frente al 91,1%; p &lt; 0,001).  Conclusiones La elevada adherencia conseguida revela que el programa de seguimiento descrito es efectivo. En el futuro son necesarios estudios de mayor duración que confirmen esta tendencia.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Adherence]]></kwd>
<kwd lng="en"><![CDATA[Medication]]></kwd>
<kwd lng="en"><![CDATA[Antipsychotic Agents]]></kwd>
<kwd lng="en"><![CDATA[Schizophrenia]]></kwd>
<kwd lng="es"><![CDATA[Adheria]]></kwd>
<kwd lng="es"><![CDATA[Medicación]]></kwd>
<kwd lng="es"><![CDATA[Antipsicóticos]]></kwd>
<kwd lng="es"><![CDATA[Esquizofrenia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<source><![CDATA[Consenso Español de Expertos para Recomendaciones de Actuación en el Tratamiento de la Esquizofrenia]]></source>
<year>2000</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Psiquiatría]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Psicofarmacología de la psicosis: elección del fármaco, adherencia al tratamiento y nuevos horizontes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Escudero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gil Molina]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pina Camacho]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[García-Cabeza]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Salud]]></source>
<year>2010</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>271-83</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment Adherence in Schizophrenia. Spanish Clinical Consensus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cañas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Olivares]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Giner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Actas Esp Psiquiatr]]></source>
<year>2007</year>
<volume>35</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence and continuation of treatment with first-and second-generation antipsychotics in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Warikoo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chakrabarti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Grover]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Indian J Psychol Med]]></source>
<year>2014</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eficiencia del programa de seguimiento farmacoterapéutico de antipsicóticos parenterales de acción prolongada en el área sanitaria de Santiago de Compostela]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Mourelle]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Durán Parrondo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[López-Pardo Pardo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Carracedo-Martínez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Gac Sanit]]></source>
<year>2016</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Medication adherence in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Psychiatr]]></source>
<year>2012</year>
<volume>2</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>74-82</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velligan]]></surname>
<given-names><![CDATA[DI]]></given-names>
</name>
<name>
<surname><![CDATA[Weiden]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sajatovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Carpenter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<collab>Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness</collab>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2009</year>
<volume>70</volume>
<numero>Suppl 4</numero>
<issue>Suppl 4</issue>
<page-range>1-46</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marcus]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Zummo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pettit]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Stoddard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Doshi]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[J Manag Care Spec Pharm]]></source>
<year>2015</year>
<volume>21</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>754-69</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez Casares]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Cañas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso Escolano]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hidalgo Borrajo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Morales]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[CNS Spectr]]></source>
<year>2010</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>327-38</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antipsicóticos inyectables de liberación prolongada para el tratamiento de la esquizofrenia en España]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arango]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Baeza]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bernardo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cañas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dios]]></surname>
<given-names><![CDATA[C de]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Marsá]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Psiquiatr Salud Ment]]></source>
<year>2018</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
